Suppr超能文献

当怀疑存在受体二聚化时结合数据的拟合

On the fitting of binding data when receptor dimerization is suspected.

作者信息

Giraldo J

机构信息

Grup Biomatemàtic de Recerca, Institut de Neurociències and Unitat de Bioestadística, Universitat Autònoma de Barcelona, Bellaterra, Spain.

出版信息

Br J Pharmacol. 2008 Sep;155(1):17-23. doi: 10.1038/bjp.2008.234. Epub 2008 Jun 9.

Abstract

Mechanistic and empirical modelling are compared in context of dimeric receptors. In particular, the supposed advantages of the two-state dimer model for fitting of binding data with respect to classical approaches such as the two-independent sites model are investigated. The two models are revisited from both the mechanistic and empirical point of views. The problem of overparameterized models and the benefits of the concurrent use of mechanistic and empirical models for mechanism analysis are discussed. The pros and cons of mathematical models are examined with special emphasis given to the interpretation of the connection between the shapes of the curves and receptor cooperativity. It is shown that a given pharmacological phenotype (curve shape) can be obtained from different receptor genotypes (as, for instance, non-interconvertible monomeric receptor species, receptor-G protein interactions and dimeric receptors), though values of the Hill coefficient greater than one are indicative of receptor oligomerization. The existence of a relationship between the recently defined dimer cooperativity index and the more familiar Hill coefficient is proven.

摘要

在二聚体受体的背景下对机理模型和经验模型进行了比较。特别地,研究了二态二聚体模型在拟合结合数据方面相对于诸如双独立位点模型等经典方法的假定优势。从机理和经验两个角度重新审视了这两种模型。讨论了模型参数过多的问题以及同时使用机理模型和经验模型进行机理分析的好处。特别强调了曲线形状与受体协同性之间联系的解释,对数学模型的优缺点进行了研究。结果表明,给定的药理学表型(曲线形状)可以从不同的受体基因型(例如,不可相互转化的单体受体种类、受体 - G蛋白相互作用和二聚体受体)获得,尽管希尔系数大于1的值表明受体寡聚化。证明了最近定义的二聚体协同性指数与更为人熟知的希尔系数之间存在关系。

相似文献

2
Modeling cooperativity effects in dimeric G protein-coupled receptors.二聚体 G 蛋白偶联受体协同作用的建模。
Prog Mol Biol Transl Sci. 2013;115:349-73. doi: 10.1016/B978-0-12-394587-7.00008-7.

引用本文的文献

本文引用的文献

1
How and why do GPCRs dimerize?G蛋白偶联受体(GPCRs)如何以及为何会二聚化?
Trends Pharmacol Sci. 2008 May;29(5):234-40. doi: 10.1016/j.tips.2008.02.004. Epub 2008 Apr 1.
4
Modeling the binding and function of metabotropic glutamate receptors.模拟代谢型谷氨酸受体的结合与功能。
J Pharmacol Exp Ther. 2008 May;325(2):443-56. doi: 10.1124/jpet.107.133967. Epub 2008 Feb 20.
6
G-protein-coupled receptor heteromers: function and ligand pharmacology.G蛋白偶联受体异聚体:功能与配体药理学
Br J Pharmacol. 2008 Mar;153 Suppl 1(Suppl 1):S90-8. doi: 10.1038/sj.bjp.0707571. Epub 2007 Nov 26.
7
Why the Schild method is better than Schild realised.为什么希尔氏方法比希尔所意识到的更好。
Trends Pharmacol Sci. 2007 Dec;28(12):608-14. doi: 10.1016/j.tips.2007.09.011. Epub 2007 Nov 26.
10
Allosteric properties of G protein-coupled receptor oligomers.G蛋白偶联受体寡聚体的变构特性。
Pharmacol Ther. 2007 Sep;115(3):410-8. doi: 10.1016/j.pharmthera.2007.06.004. Epub 2007 Jun 27.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验